Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 60472-60473 [2014-23855]
Download as PDF
<![CDATA[
60472
Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
hours
Type of respondent
Form name
Site Coordinator ................................
Site Coordinator Interview Guide .....
18
1
1.5
27
Total ...........................................
...........................................................
........................
........................
........................
72
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
[FR Doc. 2014–23865 Filed 10–6–14; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The meeting announced below
concerns Workers’ Compensation
Surveillance, PAR14–227, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Centers for Disease Control and
Prevention
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the charter
for the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
September 18, 2016.
For information, contact Catherine
Ramadei, Acting Designated Federal
Officer, Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, 1600
Clifton Road NE., Mailstop K48, Atlanta,
Georgia 30333, telephone (770) 488–
4796 or fax (404) 248–4152.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Time and Date: 11:00 a.m.–7:00 p.m.,
November 5, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Workers’ Compensation
Surveillance, PAR14–227, initial review.’’
Contact Person for More Information:
Donald Blackman, Ph.D., Scientific Review
Officer, CDC, 2400 Century Center Parkway
NE., 4th Floor, Room 4204, Mailstop E–74,
Atlanta, Georgia 30345, Telephone: (404)
498–6185, DYB7@CDC.GOV .
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23854 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2014–23858 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:15 Oct 06, 2014
Jkt 235001
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 8:15 a.m.–4:30 p.m.,
Pacific Daylight Time, November 6,
2014.
Public Comment Time and Date: 4:30
p.m.–5:30 p.m., Pacific Daylight Time,
November 6, 2014.
Place: Hilton Garden Inn Los Angeles/
Redondo Beach, 2410 Marine Avenue,
Redondo Beach, CA 90278, Phone: 310–
727–9999; Fax: 310–727–9998. Audio
Conference Call via FTS Conferencing.
The USA toll-free, dial-in number is 1–
866–659–0537 with a pass code of
9933701.
Live Meeting Connection: https://
www.livemeeting.com/cc/cdc/join?id=
ZN5GQZ&role=attend&pw=ABRWH;
Meeting ID: ZN5GQZ; Entry Code:
ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
E:\FR\FM\07OCN1.SGM
07OCN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2015.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the Advisory Board meeting includes:
NIOSH Program Update; Department of
Labor Program Update; Department of
Energy Program Update; SEC Issues
Work Group Report on ‘‘Sufficient
Accuracy’’/Co-Worker Dose Modeling;
SEC Petitions Update; an update on SEC
and Site Profile work for the Area IV of
the Santa Susana Field Laboratory
(Ventura County, CA); and Board Work
Session.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted to the contact person below
well in advance of the meeting. Any
written comments received will be
provided at the meeting in accordance
with the redaction policy provided
below.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her personal information, no attempt
will be made to redact the name;
however, NIOSH will redact other
personally identifiable information,
such as contact information, social
security numbers, case numbers, etc., of
the commenter.
(2) If an individual in making a
statement reveals personal information
(e.g., medical or employment
VerDate Sep<11>2014
17:15 Oct 06, 2014
Jkt 235001
information) about themselves that
information will not usually be
redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator
will, however, review such revelations
in accordance with the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third
party, that information will be reviewed
by the NIOSH FOIA coordinator, and
upon determination, if deemed
appropriated, such information will be
redacted, unless the disclosure is made
by the third party’s authorized
representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning
a deceased third party may be disclosed;
however, such information will be
redacted if (a) the disclosure is made by
an individual other than the survivor
claimant, a parent, spouse, or child, or
the authorized representative of the
deceased third party; (b) if it is unclear
whether the third party is living or
deceased; or (c) the information is
unrelated or irrelevant to the purpose of
the disclosure.
The Board will take reasonable steps
to ensure that individuals making
public comment are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include: (a) A statement read at the start
of each public comment period stating
that transcripts will be posted and
names of speakers will not be redacted;
(b) A printed copy of the statement
mentioned in (a) above will be
displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road
NE., MS E–20, Atlanta, Georgia 30333,
telephone: (513) 533–6800, toll free: 1–
800–CDC–INFO, email: dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for the Centers
for Disease Control and Prevention and
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
60473
the Agency for Toxic Substances and
Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23855 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Date and Time: October 29, 2014, EST,
10:30 a.m.–5:00 p.m.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and
the passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 79, Number 194 (Tuesday, October 7, 2014)]
[Notices]
[Pages 60472-60473]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23855]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 8:15 a.m.-4:30 p.m., Pacific Daylight Time, November
6, 2014.
Public Comment Time and Date: 4:30 p.m.-5:30 p.m., Pacific Daylight
Time, November 6, 2014.
Place: Hilton Garden Inn Los Angeles/Redondo Beach, 2410 Marine
Avenue, Redondo Beach, CA 90278, Phone: 310-727-9999; Fax: 310-727-
9998. Audio Conference Call via FTS Conferencing. The USA toll-free,
dial-in number is 1-866-659-0537 with a pass code of 9933701.
Live Meeting Connection: https://www.livemeeting.com/cc/cdc/join?id=ZN5GQZ&role=attend&pw=ABRWH; Meeting ID: ZN5GQZ; Entry Code:
ABRWH.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines which have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule, advice on methods of dose reconstruction which have
also been promulgated by HHS as a final rule, advice on the scientific
[[Page 60473]]
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program, and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters for Discussion: The agenda for the Advisory Board meeting
includes: NIOSH Program Update; Department of Labor Program Update;
Department of Energy Program Update; SEC Issues Work Group Report on
``Sufficient Accuracy''/Co-Worker Dose Modeling; SEC Petitions Update;
an update on SEC and Site Profile work for the Area IV of the Santa
Susana Field Laboratory (Ventura County, CA); and Board Work Session.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted to the contact person below well in advance of the meeting.
Any written comments received will be provided at the meeting in
accordance with the redaction policy provided below.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her personal information,
no attempt will be made to redact the name; however, NIOSH will redact
other personally identifiable information, such as contact information,
social security numbers, case numbers, etc., of the commenter.
(2) If an individual in making a statement reveals personal
information (e.g., medical or employment information) about themselves
that information will not usually be redacted. The NIOSH Freedom of
Information Act (FOIA) coordinator will, however, review such
revelations in accordance with the Federal Advisory Committee Act and
if deemed appropriate, will redact such information.
(3) If a commenter reveals personal information concerning a living
third party, that information will be reviewed by the NIOSH FOIA
coordinator, and upon determination, if deemed appropriated, such
information will be redacted, unless the disclosure is made by the
third party's authorized representative under the Energy Employees
Occupational Illness Compensation Program Act (EEOICPA) program.
(4) In general, information concerning a deceased third party may
be disclosed; however, such information will be redacted if (a) the
disclosure is made by an individual other than the survivor claimant, a
parent, spouse, or child, or the authorized representative of the
deceased third party; (b) if it is unclear whether the third party is
living or deceased; or (c) the information is unrelated or irrelevant
to the purpose of the disclosure.
The Board will take reasonable steps to ensure that individuals
making public comment are aware of the fact that their comments
(including their name, if provided) will appear in a transcript of the
meeting posted on a public Web site. Such reasonable steps include: (a)
A statement read at the start of each public comment period stating
that transcripts will be posted and names of speakers will not be
redacted; (b) A printed copy of the statement mentioned in (a) above
will be displayed on the table where individuals sign up to make public
comments; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in the
Federal Register Notice that announces Board and Subcommittee meetings.
Contact Person for More Information: Theodore Katz, Designated
Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., MS E-20, Atlanta,
Georgia 30333, telephone: (513) 533-6800, toll free: 1-800-CDC-INFO,
email: dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-23855 Filed 10-6-14; 8:45 am]
BILLING CODE 4163-18-P
